FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4311778127> ?p ?o ?g. }

• W4311778127 endingPage "e2247180" @default.
• W4311778127 startingPage "e2247180" @default.
• W4311778127 abstract "Older US veterans commonly receive health care outside of the US Veterans Health Administration (VHA) through Medicare, which may increase receipt of low-value care and subsequent care cascades.To characterize the frequency, cost, and source of low-value prostate-specific antigen (PSA) testing and subsequent care cascades among veterans dually enrolled in the VHA and Medicare and to determine whether receiving a PSA test through the VHA vs Medicare is associated with more downstream services.This retrospective cohort study used VHA and Medicare administrative data from fiscal years (FYs) 2017 to 2018. The study cohort consisted of male US veterans dually enrolled in the VHA and Medicare who were aged 75 years or older without a history of prostate cancer, elevated PSA, prostatectomy, radiation therapy, androgen deprivation therapy, or a urology visit. Data were analyzed from December 15, 2020, to October 20, 2022.Receipt of low-value PSA testing.Differences in the use and cost of cascade services occurring 6 months after receipt of a low-value PSA test were assessed for veterans who underwent low-value PSA testing in the VHA and Medicare compared with those who did not, adjusted for patient- and facility-level covariates.This study included 300 393 male US veterans at risk of undergoing low-value PSA testing. They had a mean (SD) age of 82.6 (5.6) years, and the majority (264 411 [88.0%]) were non-Hispanic White. Of these veterans, 36 459 (12.1%) received a low-value PSA test through the VHA, which was associated with 31.2 (95% CI, 29.2 to 33.2) additional cascade services per 100 veterans and an additional $24.5 (95% CI, $20.8 to $28.1) per veteran compared with the control group. In the same cohort, 17 981 veterans (5.9%) received a PSA test through Medicare, which was associated with 39.3 (95% CI, 37.2 to 41.3) additional cascade services per 100 veterans and an additional $35.9 (95% CI, $31.7 to $40.1) per veteran compared with the control group. When compared directly, veterans who received a PSA test through Medicare experienced 9.9 (95% CI, 9.7 to 10.1) additional cascade services per 100 veterans compared with those who underwent testing within the VHA.The findings of this cohort study suggest that US veterans dually enrolled in the VHA and Medicare commonly experienced low-value PSA testing and subsequent care cascades through both systems in FYs 2017 and 2018. Care cascades occurred more frequently through Medicare compared with the VHA. These findings suggest that low-value PSA testing has substantial downstream implications for patients and may be especially challenging to measure when care occurs in multiple health care systems." @default.
• W4311778127 created "2022-12-28" @default.
• W4311778127 creator A5010861527 @default.
• W4311778127 creator A5014692669 @default.
• W4311778127 creator A5017385124 @default.
• W4311778127 creator A5019109829 @default.
• W4311778127 creator A5019670773 @default.
• W4311778127 creator A5035460856 @default.
• W4311778127 creator A5039605963 @default.
• W4311778127 creator A5046018337 @default.
• W4311778127 creator A5062056699 @default.
• W4311778127 creator A5064284968 @default.
• W4311778127 creator A5066058484 @default.
• W4311778127 creator A5087949120 @default.
• W4311778127 creator A5090971178 @default.
• W4311778127 date "2022-12-15" @default.
• W4311778127 modified "2023-09-27" @default.
• W4311778127 title "Assessment of Care Cascades Following Low-Value Prostate-Specific Antigen Testing Among Veterans Dually Enrolled in the US Veterans Health Administration and Medicare Systems" @default.
• W4311778127 cites W1523497330 @default.
• W4311778127 cites W1555872688 @default.
• W4311778127 cites W1678840505 @default.
• W4311778127 cites W1852041486 @default.
• W4311778127 cites W1972033537 @default.
• W4311778127 cites W2002355482 @default.
• W4311778127 cites W2036193982 @default.
• W4311778127 cites W2045291273 @default.
• W4311778127 cites W2057780602 @default.
• W4311778127 cites W2063791168 @default.
• W4311778127 cites W2069145210 @default.
• W4311778127 cites W2110818436 @default.
• W4311778127 cites W2138627586 @default.
• W4311778127 cites W2238461883 @default.
• W4311778127 cites W2243742560 @default.
• W4311778127 cites W2316714072 @default.
• W4311778127 cites W2560762298 @default.
• W4311778127 cites W2800738672 @default.
• W4311778127 cites W2885728201 @default.
• W4311778127 cites W2889416085 @default.
• W4311778127 cites W2948332559 @default.
• W4311778127 cites W2953790216 @default.
• W4311778127 cites W2963310568 @default.
• W4311778127 cites W3034041588 @default.
• W4311778127 cites W3081039335 @default.
• W4311778127 cites W3087627463 @default.
• W4311778127 cites W3087770866 @default.
• W4311778127 cites W3098198535 @default.
• W4311778127 cites W3125228632 @default.
• W4311778127 cites W3141246541 @default.
• W4311778127 cites W4224240400 @default.
• W4311778127 cites W4250958442 @default.
• W4311778127 cites W4252039761 @default.
• W4311778127 cites W4283827460 @default.
• W4311778127 doi "https://doi.org/10.1001/jamanetworkopen.2022.47180" @default.
• W4311778127 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/36520431" @default.
• W4311778127 hasPublicationYear "2022" @default.
• W4311778127 type Work @default.
• W4311778127 citedByCount "2" @default.
• W4311778127 countsByYear W43117781272023 @default.
• W4311778127 crossrefType "journal-article" @default.
• W4311778127 hasAuthorship W4311778127A5010861527 @default.
• W4311778127 hasAuthorship W4311778127A5014692669 @default.
• W4311778127 hasAuthorship W4311778127A5017385124 @default.
• W4311778127 hasAuthorship W4311778127A5019109829 @default.
• W4311778127 hasAuthorship W4311778127A5019670773 @default.
• W4311778127 hasAuthorship W4311778127A5035460856 @default.
• W4311778127 hasAuthorship W4311778127A5039605963 @default.
• W4311778127 hasAuthorship W4311778127A5046018337 @default.
• W4311778127 hasAuthorship W4311778127A5062056699 @default.
• W4311778127 hasAuthorship W4311778127A5064284968 @default.
• W4311778127 hasAuthorship W4311778127A5066058484 @default.
• W4311778127 hasAuthorship W4311778127A5087949120 @default.
• W4311778127 hasAuthorship W4311778127A5090971178 @default.
• W4311778127 hasBestOaLocation W43117781271 @default.
• W4311778127 hasConcept C121608353 @default.
• W4311778127 hasConcept C126322002 @default.
• W4311778127 hasConcept C136764020 @default.
• W4311778127 hasConcept C160735492 @default.
• W4311778127 hasConcept C162324750 @default.
• W4311778127 hasConcept C167135981 @default.
• W4311778127 hasConcept C194828623 @default.
• W4311778127 hasConcept C2775969662 @default.
• W4311778127 hasConcept C2777899217 @default.
• W4311778127 hasConcept C2778979077 @default.
• W4311778127 hasConcept C2779466945 @default.
• W4311778127 hasConcept C2780192828 @default.
• W4311778127 hasConcept C2781406297 @default.
• W4311778127 hasConcept C41008148 @default.
• W4311778127 hasConcept C50522688 @default.
• W4311778127 hasConcept C71924100 @default.
• W4311778127 hasConcept C72563966 @default.
• W4311778127 hasConceptScore W4311778127C121608353 @default.
• W4311778127 hasConceptScore W4311778127C126322002 @default.
• W4311778127 hasConceptScore W4311778127C136764020 @default.
• W4311778127 hasConceptScore W4311778127C160735492 @default.
• W4311778127 hasConceptScore W4311778127C162324750 @default.
• W4311778127 hasConceptScore W4311778127C167135981 @default.
• W4311778127 hasConceptScore W4311778127C194828623 @default.
• W4311778127 hasConceptScore W4311778127C2775969662 @default.

• next